Colgate-Palmolive (CL)
Consumer Staples · Household & Personal Products · NYSE
A global leader in consumer health and hygiene, owning iconic brands in oral care, personal care, and pet nutrition.
What Colgate-Palmolive does
Colgate-Palmolive is a global consumer products company focused on Oral Care, Personal Care, Home Care, and Pet Nutrition. The company markets its products under recognized brand names worldwide, selling them primarily to grocery retailers, wholesalers, and distributors.
Themes: oral care, personal care, home care products, pet nutrition, consumer staples
Fundamentals
- Price$91.08 as of 2026-08-21 close
- Market cap$72.6B as of 2026-08-21
- 1-year return+5.6% 2025-08-21 close $86.28 → 2026-08-21 close $91.08
- P/E36.49 as of 2026-08-24
- Net margin+9.7% as of 2026-08-24
- Gross margin+60.4% as of 2026-08-24
- ROE+631.1% as of 2026-08-24
- Debt / equity33.29 as of 2026-08-24
- Revenue growth (YoY)+5.2% as of 2026-08-24
- Revenue CAGR (3y)+4.3% SEC XBRL
- Beta0.32 as of 2026-08-24
- Last reported earnings2026-07-31 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +2.5%; 1-year non-decreasing per-share dividend streak (SEC XBRL).
How CL compares in its sector
- price-to-earnings ratiotop 25% 97 covered Consumer Staples peers, as of 2026-08-24
- net profit margintop 25% 116 covered Consumer Staples peers, as of 2026-08-24
- operating margintop 25% 116 covered Consumer Staples peers, as of 2026-08-24
- gross margintop 25% 116 covered Consumer Staples peers, as of 2026-08-24
- return on equitytop 10% 116 covered Consumer Staples peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 109 covered Consumer Staples peers
- indicated dividend yieldmiddle range 77 covered Consumer Staples peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)top 10% 110 covered Consumer Staples peers, as of FY2025
Position among covered Consumer Staples companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
CL is in the Consumer Staples Short-term Top 10.
Consumer Staples Short-term Top 10 — since 18 Aug 2026
Long-term score
41.3 #788 of 987 scored · #29 of 49 in Consumer Staples
Profitability 72nd (return on equity 631.1%, operating margin 14.9%) and long-term trend 53rd (it is 8.3% below its highest point of the past year); weakest is valuation (8th, price to book 307.7, price to earnings 36).
Short-term score
55.4 #452 of 1,704 scored · #17 of 69 in Consumer Staples
Volume and participation 69th: it gapped 4.8% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; setup 67th: day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 8% of the past ~6 months), which often precedes a bigger move; weakest is momentum 41st: MACD momentum is negative.
Consumer Staples Short-term Top 10
In this list since 18 Aug 2026 — currently 6th in the list (3 days)
- Entered 18 Aug 2026: first selection for this list at rank 10, score 58.9.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, CL's dividend was covered by reported results (earnings payout 86%, free-cash-flow payout 50%). This describes past coverage, not a forecast.
- Earnings payout86% dividends / net income
- Free-cash-flow payout50% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Colgate-Palmolive looks technically
Colgate-Palmolive (CL) is trading 4.8% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 125 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 8, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 48, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 6 trading days ago (its momentum flipped negative). It made a new 20-day low about 2 trading days ago. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 8% of the past ~6 months), which often precedes a bigger move.
Trend
8
| Distance from the 200-day | it is trading 4.8% above its 200-day average, the long-term trend line — a longer-term uptrend | +4.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $91.68 | $91.68 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $86.90 | $86.90 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 94.152. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 125 trading days ago — a "golden cross", a bullish long-term signal | 125 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 8, below the 25 that marks a real trend) | 8.3 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 48, neither overbought (above 70) nor oversold (below 30) | 47.9 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($89.16 to $94.15) — its "stochastic" reading is 38 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 38.5 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 6 trading days ago (its momentum flipped negative) | 6 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $99.33 | $99.33 |
|---|---|---|
| From the 52-week high | it is 8.3% below its 52-week high (its highest price of the past year) | -8.3% |
| Above the 52-week low | it is 22.2% above its 52-week low (its lowest price of the past year) | +22.2% |
| Below the 52-week high | it is 8.3% below its highest point of the past year | 8.3% |
| Since a 20-day breakout | it made a new 20-day low about 2 trading days ago | 2 sessions |
| Since a 55-day breakout | it made a new 55-day high about 36 trading days ago | 36 sessions |
| All-time high | its highest closing price on record is $109.30 (set on 2024-09-05) | $109.30 |
| Given back of the 52-week move | over the past year its closes ranged ($74.98 to $99.14), and it has given back roughly a third of its rise from last year’s low — 33% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $83.44 to $84.21. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 33.4% |
| From the all-time high | it is 16.7% below its all-time high | -16.7% |
| Nearest price level | it is trading 1.9% above a support level at $89.38 — a price it turned at 8 times since 2024-11-06, most recently on 2026-08-04. Since 2024-08-21 it has 7 such levels below the current price and 4 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -1.9% |
| All-time low | its lowest closing price on record is $9.77 (set on 1996-07-31) | $9.77 |
| Above the all-time low | it is 832.7% above its all-time low | +832.7% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 8% of the past ~6 months), which often precedes a bigger move | 8th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $2.13 between its high and its low — about 2.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $2.13 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $89.69 and $94.22 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $89.69 – $91.95 – $94.22 |
| Typical daily range (% of price) | its price moves about 2.3% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.3% |
| Stretch from the 200-day average | it is trading 2.0 daily ranges above its 200-day average price (4.8% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 2.0 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.89× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a bearish engulfing | 2 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 2 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.2% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.2% |
|---|---|---|
| Open gap | it gapped 4.8% above the previous close 48 sessions ago and has not traded back through the level it left behind at 86.07 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +4.8% |
| Gap filled | a 2.3% gap up opened on 2026-07-28 has been "filled" 17 sessions ago — price traded back through the level the gap left behind, and it took 1 session to close | 17 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 1.7 percentage points (the stock gained 0.6% while the market gained 2.3%) | -1.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 2.4 percentage points (the stock gained 0.7% while the market gained 3.1%) | -2.4% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 15.3 percentage points (the stock lost 4.2% while the market gained 11.1%) | -15.3% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 14.9 percentage points (the stock gained 5.6% while the market gained 20.5%) | -14.9% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: a fresh 20-day low, MACD momentum is negative, lagging the market over 6 months — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is thin, spanning 1.6% of the share price, which is taken to mean a barrier that gives way easily. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 2% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $88.90 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +2.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is 1% below the average price paid since it last reported on 2026-07-31 (its 10-Q), so the typical buyer over that stretch is under water. That average is $91.77 — a volume-weighted average of daily closes over 16 sessions, not a true tick-by-tick VWAP. | -0.8% |
Price levels it has turned at before
CL last closed at $91.08 on 2026-08-21. Since 2024-08-21 it has turned at 7 prices below its last close and 4 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $89.38 | Support | 1.9% below the last close | turned there 8 times · 2024-11-06 to 2026-08-04 |
| $93.12 | Resistance | 2.2% above the last close | turned there 10 times · 2024-12-10 to 2026-08-06 |
| $87.72 | Support | 3.7% below the last close | turned there twice · 2025-04-09 to 2025-08-20 |
| $95.91 | Resistance | 5.3% above the last close | turned there four times · 2025-04-21 to 2026-07-28 |
| $85.96 | Support | 5.6% below the last close | turned there 13 times · 2025-01-10 to 2026-06-04 |
| $98.20 | Resistance | 7.8% above the last close | turned there five times · 2024-10-08 to 2026-02-27 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $94.15.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $84.02 and $87.89 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $94.15.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Broke down to a new 20-day low · in a Bollinger Band volatility squeeze · trendless / choppy (low ADX) · lagging the market · Trading inside the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · macd · breakout · bollinger bands
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.05 mean, 1=Strong Buy…5=Strong Sell) — 20 analysts
- Mean price target$98.95 range $87.00 – $110.00; median $100.50
Analyst estimates, as of 2026-08-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CL
- Consensus EPS estimate$0.9296 next reporting period, as of 2026-08-19
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on raw material prices and supply chain volatility.","Intense global competition and pressure on pricing strategies.","Exposure to foreign exchange rate fluctuations and geopolitical risks in international markets."]
What changed in the latest 10-Q
AI-assisted comparison of CL's 10-Q filed 2026-05-01 against the prior one filed 2025-10-31.
Risk Factors
- Added:
- In Item 1A Risk Factors (filed 2026-05-01): Reference updated to "Annual Report on Form 10-K for the year ended December 31, 2025" (vs. December 31, 2024 in older filing)
- In Item 6 Exhibits (filed 2026-05-01): New Exhibit 10-A described as "Form of Performance Stock Unit Award Agreement for the 2026-2028 Performance Cycle"
- Removed:
- In Item 6 Exhibits (filed 2025-10-31): Removed Exhibit 10-A "Form of Nonqualified Option Award Agreement used in connection with grants under the Colgate-Palmolive Company 2019 Incentive Compensation Plan"
- In Item 6 Exhibits (filed 2025-10-31): Removed Exhibit 10-B "Form of Restricted Stock Unit Award Agreement used in connection with grants under the Colgate-Palmolive Company 2019 Incentive Compensation Plan"
- Reworded:
- In Item 2 Unregistered Sales (filed 2026-05-01): Quarter period changed from "three months ended September 30, 2025" to "three months ended March 31, 2026"
- In Item 2 Unregistered Sales (filed 2026-05-01): Stock repurchase table months changed from July, August, September 2025 to January, February, March 2026
- In Item 2 Unregistered Sales (filed 2026-05-01): All share purchase quantities and prices updated to reflect Q1 2026 activity instead of Q3 2025 activity
- In Item 2 Unregistered Sales (filed 2026-05-01): Approximate dollar value of shares remaining under repurchase program changed from $4,485 million to $3,809 million
- In Item 5 Other Information - Trading Plans (filed 2026-05-01): Quarter reference changed from "three months ended September 30, 2025" to "three months ended March 31, 2026"
- In Item 6 Exhibits - Exhibit 101 (filed 2026-05-01): Period reference changed from "September 30, 2025" to "March 31, 2026"
- In Item 6 Exhibits - Exhibit 101 (filed 2026-05-01): Minor wording change: "Condensed Consolidated Statements of Changes in Shareholders' Equity" (vs. "Condensed Consolidated Statements of Changes in Shareholders' Equity" - essentially the same)
- Signature date changed from October 31, 2025 to May 1, 2026 (filed 2026-05-01)
- Notes:
- The comparison is between two quarterly 10-Q filings for different fiscal periods (Q3 2025 vs. Q1 2026); structural and numerical changes reflect this periodicity difference rather than policy modifications
- Risk Factors section in both filings states "no material changes" from their respective prior-year 10-K filings; the only change is the reference year updated from 2024 to 2025
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days.
- Last 180 days0 buys · 2 sells ($955045) — 2 selling insiders
Most recent open-market transaction: 2026-05-15. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CL's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 8 matched disclosures for CL from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding CL as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 136,246,504
- Reported value $11,612,289,531
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 3 increased, 3 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
CL had 17,767,107 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
CL had 2.23% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.84 days to cover at the same settlement.
- Reported short interest (shares) 17,767,107
- Short interest (% of shares outstanding) 2.23%
- Prior settlement (shares) 16,716,514
- Reported change 6.28%
- Days to cover (reported) 3.84
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Procter & Gamble (PG)
- Unilever
- Church & Dwight (CHD)
- Kimberly-Clark (KMB)
- Haleon
- Nestle (NSRGY)
- Mars, Incorporated
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CL vs…
Colgate-Palmolive is found in…
CL ranks in…
Frequently asked questions
What does Colgate-Palmolive (CL) do?
Colgate-Palmolive is a global consumer products company focused on Oral Care, Personal Care, Home Care, and Pet Nutrition. The company markets its products under recognized brand names worldwide, selling them primarily to grocery retailers, wholesalers, and distributors.
What sector is Colgate-Palmolive (CL) in?
Colgate-Palmolive (CL) is classified in the Consumer Staples sector. Its industry is Household & Personal Products. It trades on NYSE.
Does CL pay a dividend?
Yes — Colgate-Palmolive (CL) pays a dividend, with an indicated yield of about 2.48% and 1-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-08-24). Informational only — not financial advice.
Who are Colgate-Palmolive's (CL) competitors?
Notable peers of Colgate-Palmolive (CL) include Procter & Gamble, Unilever, Church & Dwight, Kimberly-Clark and Haleon. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in CL?
Yes — we hold 8 matched STOCK Act disclosures for CL from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Colgate-Palmolive (CL) overbought or oversold right now?
Colgate-Palmolive (CL) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 48, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CL come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.